Melanotan II plus light therapy for vitiligo repigmentation
Part of Skin clinical trials.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old
- You have nonsegmental vitiligo that has been stable (no new spots or spreading) for at least 6 months
- Your vitiligo patches cover between 3% and 20% of your body
- You are willing to have phototherapy (light treatment) sessions and avoid other vitiligo treatments during the study
- If you can become pregnant, you agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This trial tests a cream (ruxolitinib) combined with corticosteroid treatment for people with active, non-segmental vitiligo that affects the face. It aims to see how well this combination works in real-world settings.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This study tests an experimental medication (ACT-777991) taken by mouth to see if it can help repigment skin in adults with non-segmental vitiligo. It aims to learn how safe it is and how well it works.
This trial tests an oral medication (a tablet) for treating non-segmental vitiligo, a condition where white patches appear on the skin. The goal is to see if the drug can safely help bring color back to those patches.
This study tests an investigational drug (GIA632) in people with non-segmental vitiligo. It aims to see if different doses can safely and effectively restore color to white patches.
Hear when a new NonSegmental Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.